Skip to main content
Move the World.

Mammograms are the best way to screen for breast cancer, but they're also famously unpleasant and unreliable. Many women go through unnecessary surgery to remove benign lumps, and mammograms can also miss deep tumors. But a new pill promises to revolutionize diagnosis by making cancerous cells light up under infrared scans, hopefully eliminating false positives and catching hidden tumors.

False Positives: Annual mammograms are recommended by health authorities to catch breast cancer early—which they totally do. Unfortunately, along with catching more cancers, they also catch more benign growths and other abnormalities that aren't serious health risks. A study in Denmark last year found that as many as a third of women who got surgery or chemo to remove breast cancer turned out to have benign or non-life-threatening tumors. But doctors can't easily tell the difference on x-rays, so patients often err on the side of caution, choosing drastic treatments over the risks of waiting.

Making Cancer Glow: Scientists at the University of Michigan have developed a much more precise tool to both find tumors and detect benign growths. Their pill delivers a dye that tags a molecule found on cancer cells, and then lights up under an infrared scan. Doctors can fine tune what molecules get stained to distinguish between aggressive cancers and benign lumps. The best part is that infrared scans can actually go deeper than mammograms, finding tumors in dense tissue that normal screening would miss, and they don't use potentially harmful X-rays.

A Failed Drug Saves the Day: Making the dye work as a pill was important, not only because people hate needles but also because some people are allergic to IV dyes. Getting a dye from the stomach to the organs is tricky, but U-M researchers found an old, failed cancer drug that could do exactly that. The drug didn't work to stop cancer, but it could get molecules through the stomach, past the liver, into the blood and onto the tumor. When scientists gave the pills to mice with cancer and then scanned them, they saw the tumors light up.

Bottom Line: If it continues to work in humans, it will be a real breakthrough: a less painful, more accurate, and safer way to screen for breast cancer. Since half of women aren't getting mammograms now, a diagnosis that promises fewer false positives and a more comfortable test could significantly improve overall screening, while cutting down on scary and unnecessary treatments.

Up Next

Self-Driving Semis
Autonomous Trucks Are Taking to the Highways
Autonomous Trucks Are Taking to the Highways
Self-Driving Semis
Autonomous Trucks Are Taking to the Highways
Self-driving cars get all the love, but autonomous trucks are already hitting the road, with a “driver-out” demonstration scheduled for 2021.

Self-driving cars get all the love, but autonomous trucks are already hitting the road, with a “driver-out” demonstration scheduled for 2021.

Public Health
FDA: Smokeless Cigarettes Produce Less Harmful Chemicals
Smokeless Cigarettes
Public Health
FDA: Smokeless Cigarettes Produce Less Harmful Chemicals
FDA clears Philip Morris to market its smokeless cigarettes as modified risk tobacco products, which could benefit smokers battling a nicotine addiction.

FDA clears Philip Morris to market its smokeless cigarettes as modified risk tobacco products, which could benefit smokers battling a nicotine addiction.

Prosthetics
We’re One Step Closer to a Bionic, Prosthetic Eye
prosthetic eye
Prosthetics
We’re One Step Closer to a Bionic, Prosthetic Eye
A prosthetic eye may soon be possible, thanks to new research that demonstrates how to stimulate the brain to “see.”

A prosthetic eye may soon be possible, thanks to new research that demonstrates how to stimulate the brain to “see.”

Dope Science
Medical Cannabis Explained
medical cannabis
Dope Science
Medical Cannabis Explained
Medical cannabis is everywhere. We're answering your basic questions and unpacking the promises and pitfalls, based on the latest research.

Medical cannabis is everywhere. We're answering your basic questions and unpacking the promises and pitfalls, based on the latest research.

Future of Medicine
The First Universal Flu Vaccine Could Be Coming Soon
The First Universal Flu Vaccine Could Be Coming Soon
Future of Medicine
The First Universal Flu Vaccine Could Be Coming Soon
After flu season, vaccines are outdated and researchers must predict next year’s virus. But soon, we may have a universal flu vaccine that doesn't expire.

After flu season, vaccines are outdated and researchers must predict next year’s virus. But soon, we may have a universal flu vaccine that doesn't expire.

INTEL
Why Cancer Patients Should Get Genetic Sequencing
Why Cancer Patients Should Get Genetic Sequencing
Watch Now
INTEL
Why Cancer Patients Should Get Genetic Sequencing
Genomic sequencing saved his live. Now he wants everyone to have access.
Watch Now

After he was diagnosed with life-threatening prostate cancer, Intel’s Bryce Olson sequenced his genome which offered clues to new treatments for his disease. While the current standard of care for cancer patients includes surgery, radiation, and chemotherapy, genetic sequencing opens the door for new possibilities beyond these traditional approaches. Bryce explains his personal mission to encourage others to get their...

Coded
WATCH: Trailer for Our New Show, Coded
WATCH: Trailer for Our New Show, Coded
Coded
WATCH: Trailer for Our New Show, Coded
Meet the programmers on the frontlines of the war over security and privacy.
By Mike Riggs

Meet the programmers on the frontlines of the war over security and privacy.

Superhuman
The Promise of Gene Therapy
The Promise of Gene Therapy
Watch Now
Superhuman
The Promise of Gene Therapy
When Karen was told her daughter had an incurable disease, she started a gene therapy company to find a cure.
Watch Now

When doctors told Karen there was no cure for her daughter’s brain disease, she took matters into her own hands. With no scientific background, she created a gene therapy business that can fix the faulty genes in patients like her daughter. Now she’s racing against the clock to extend her daughter’s life and improve the lives of others.